Pharmacy sales in the United States are positive with growth expected to increase 20% 2005-2008 according to data published by benefit management companies and a market intelligence firm. The rate of increase is lower than it has been in the past f Continue Reading...
Wal-Mart Stores, Inc. Comprehensive Analysis of SEC form 10-k and the DEF-14A Proxy statement Contents 1. Background 1 2. Walmart’s Business Strategy 3 3. Stakeholder Evaluation 4 3.1. Internal Stakeholders 4 3.1.1. Shareholders 5 3 Continue Reading...
This situation was also due to slower growth in prescription drugs. Other categories that reported slower growth include: physician and clinical services, home health care, and other professional services. Regarding prescription drug spending, the Continue Reading...
